Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

rituximab

riTUXimab
  • Restricted Utilize most cost-effective product for FDA-approved indications
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Riabni INJECTION, INTRAVENOUS 10 mg/mL    
Rituxan SOLUTION, INTRAVENOUS 10 mg/mL    
Ruxience SOLUTION, INTRAVENOUS 10 mg/mL    
Truxima SOLUTION, INTRAVENOUS 10 mg/mL    
VIEW MORE Antineoplastic Agents
Comments:

For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents 

Drug reviewed for Outpatient Infusion (updated May 7, 2021)

Truxima, Riabni, and Ruxience are considered therapeutically equivalent to Rituxan for FDA approved indications and literature supported off-label uses. The most cost effective product will be used in a specific setting, time period, or patient case.

 

A second clinical verification by the Oncology Clinical Specialists is not required for non-oncologic indications including, but not limited to, rheumatology, nephrology, and benign hematology. These orders may be verified by the covering pharmacist as clinically appropriate. For more information: Rituximab for Non-Malignant Indications 

 

Outpatient riTUXimab cycle 2+ rapid infusion protocol available for adults. 

RiTUXimab cycle 2+ rapid infusion (adults)

Reviewed: 23 July 2019 (Truxima). October 22, 2019, 24 March 2020 (Ruxience), April 2026 (Riabni)  

Rituximab-arrx (RIABNI) Spotlight.pdf

Last updated: Jun. 2, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved